Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Mar 2023

  Comment

  In CKD, once-daily empagliflozin reduced progression of kidney disease or CV death at 2 y.

  EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388:117-27. 36331190.

  explore further… mark as read…

• Ann. Intern. Med. · Mar 2023

  Editorial Comment

  2022 Clinical Practice Guideline Update for Diabetes Management of Chronic Kidney Disease: An Important First Step, More Work to Do.

  no abstract available

  expand abstract… or not…

• Ann. Intern. Med. · Mar 2023

  Firearm Owners' Preferences for Locking Devices: Results of a National Survey.

  no abstract available

  keep reading… or not…

• Ann. Intern. Med. · Mar 2023

  Annals Consult Guys - Could This Patient Have Heyde Syndrome?

  no abstract available

  read on… or not…

• Ann. Intern. Med. · Mar 2023

  Comment Letter

  Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.

  no abstract available

  explore further… or not…